CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Prime: A Buy Due To BLA Filing H1 '27 And Continued PM647 Advancement

BLA FilingPM647Positive
AI Analysis

Summary

Prime is expected to file a BLA for an undisclosed indication in H1 2027, with continued advancement of PM647 in development. The company is positioned as a buy candidate based on these upcoming regulatory milestones.

Importance:7/10
Sentiment:
0.60
BLA_Filingdrug_developmentregulatory_progress

Read the original article

Published by Seeking Alpha Healthcare on September 25, 2026 8:00 PM

Read Original